+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Robotics in Healthcare - Thematic Intelligence

  • PDF Icon


  • 81 Pages
  • November 2022
  • Region: Global
  • GlobalData
  • ID: 5699702
Macroeconomic factors will drive healthcare's use of robotics

The healthcare industry, including pharma, medical devices, and healthcare providers and payors, is often risk-averse compared to other sectors when adopting new technologies. However, challenges such as COVID-19, environmental, social, and governance (ESG) issues, and aging populations are driving digital transformation. The use of robots to address these challenges will become crucial as increased demand for healthcare services coincides with heightened economic uncertainty.

Medical robots improve the standard of care

Healthcare providers will increasingly invest in medical robots to compensate for staff shortages and improve the standard of care. Care robots will dramatically cut the cost of nursing elderly patients, and even provide emotional support and human-like interaction. While surgical robots improve patient outcomes, reduce human error, and decrease the length of hospital stays. New surgical robotic models will provide entirely new surgical possibilities, for example, micro-robots will be used to treat difficult-to-treat diseases such as those in the brain.

Double-digit growth is expected in the next decade

Robotics is a fast-growing industry. The publisher expects every segment of the robotics market to grow over the next decade. According to publisher forecasts, the medical robotics market was worth $4.7 billion in 2020, and by 2030, it will have grown at a compound annual growth rate (CAGR) of 12% to $14.5 billion. Surgical robots will drive the medical robotics market, bolstered by the growth of sales in orthopedic and neurosurgical robots.

Industrial robots will enhance smart pharma manufacturing

The deployment of robotics in manufacturing can lead to substantial enhancements beyond productivity increases, resulting in better compliance, consistency, and operational excellence. Adoption is still in the early stages, however, the publisher's Smart Pharma 2021 survey found that industry professionals believe robotics will be the most disruptive technology in pharma manufacturing processes. Deploying robots in manufacturing will enable the large-scale development of therapeutic products needed for emerging treatments such as cell & gene therapy.


  • This report is a thematic brief, which identifies those companies most likely to succeed in a world filled with disruptive threats.
  • Inside, we predict how each theme will evolve and identify the leading and disrupting companies.
  • The report covers the Robotics theme.

Reasons to Buy

  • The publisher's thematic research ecosystem is a single, integrated global research platform that provides an easy-to-use framework for tracking all themes across all companies in all sectors. It has a proven track record of identifying the important themes early, enabling companies to make the right investments ahead of the competition, and secure that all-important competitive advantage.
  • Develop and design your corporate strategies through an in-house expert analysis of robotics by understanding the primary ways in which this theme is impacting the medical devices industry.
  • Stay up to date on the industry's major players and where they sit in the value chain.
  • Identify emerging industry trends to gain a competitive advantage.

Table of Contents

  • Executive Summary
  • Robotics Value Chain
  • Key players in the robotics value chain
  • Robot manufacturing
  • Hardware components
  • Software components
  • Robotics as a service
  • Healthcare Challenges
  • The Impact of Robotics on Healthcare
  • Case Studies
  • Data Analysis
  • Market size and growth forecasts
  • Mergers and acquisitions
  • Capital raising
  • Patent trends
  • Company filings trends
  • Hiring trends
  • Social media trends
  • Robotics timeline
  • Companies
  • Sector Scorecard
  • Medical devices sector scorecard
  • Drug manufacturing sector scorecard
  • Glossary
  • Further Reading
  • Our Thematic Research Methodology
  • About the Publisher
  • Contact the Publisher

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AstraZeneca
  • Bayer
  • Eli Lilly
  • Merck Group
  • Pfizer
  • Takeda
  • Apollo Healthcare
  • Galaxy Care Hospital
  • Guy’s and St Thomas’ NHS Foundation Trust
  • HCA Healthcare
  • Hospital for Special Surgery
  • Globus Medical
  • Intuitive Surgical
  • Johnson & Johnson (J&J)
  • Smith & Nephew
  • Stryker
  • Thermo Fisher Scientific
  • Zimmer Biomet